These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32203145)
61. Increased frequency of CD39 Rahimifard K; Shahbazi M; Oliaei F; Akbari R; Tarighi M; Mohammadnia-Afrouzi M Transpl Immunol; 2023 Jun; 78():101823. PubMed ID: 36921728 [TBL] [Abstract][Full Text] [Related]
62. High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma. Zhang B; Cheng B; Li FS; Ding JH; Feng YY; Zhuo GZ; Wei HF; Zhao K Tumour Biol; 2015 Dec; 36(12):9411-9. PubMed ID: 26113408 [TBL] [Abstract][Full Text] [Related]
63. Expression of CD39 Is Correlated With HIV DNA Levels in Naïve Tregs in Chronically Infected ART Naïve Patients. Song JW; Huang HH; Zhang C; Yang HG; Zhang JY; Xu RN; Jin L; Shi M; Wang FS; Jiao YM Front Immunol; 2019; 10():2465. PubMed ID: 31681335 [No Abstract] [Full Text] [Related]
64. Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia. Abousamra NK; Salah El-Din M; Hamza Elzahaf E; Esmael ME Leuk Lymphoma; 2015 Jan; 56(1):113-9. PubMed ID: 24684231 [TBL] [Abstract][Full Text] [Related]
65. TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis. Peres RS; Donate PB; Talbot J; Cecilio NT; Lobo PR; Machado CC; Lima KWA; Oliveira RD; Carregaro V; Nakaya HI; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; Cunha FQ J Autoimmun; 2018 Jun; 90():49-58. PubMed ID: 29426578 [TBL] [Abstract][Full Text] [Related]
66. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium. Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627 [TBL] [Abstract][Full Text] [Related]
67. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. Parodi A; Battaglia F; Kalli F; Ferrera F; Conteduca G; Tardito S; Stringara S; Ivaldi F; Negrini S; Borgonovo G; Simonato A; Traverso P; Carmignani G; Fenoglio D; Filaci G Cancer Immunol Immunother; 2013 May; 62(5):851-62. PubMed ID: 23359087 [TBL] [Abstract][Full Text] [Related]
76. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916 [TBL] [Abstract][Full Text] [Related]
77. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses. Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090 [TBL] [Abstract][Full Text] [Related]
78. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia. Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759 [TBL] [Abstract][Full Text] [Related]
79. CD4 and CD8 double-negative adult T-cell leukemia/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus. Lin TH; Wu HC; Hsieh YC; Tseng CE; Ichinohasama R; Chuang SS Pathol Int; 2013 Feb; 63(2):132-7. PubMed ID: 23464972 [TBL] [Abstract][Full Text] [Related]
80. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Eltzschig HK; Köhler D; Eckle T; Kong T; Robson SC; Colgan SP Blood; 2009 Jan; 113(1):224-32. PubMed ID: 18812468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]